NLM Digital Collections

Search

Start Over Subjects Government Regulation ✖Remove constraint Subjects: Government Regulation Subjects United States ✖Remove constraint Subjects: United States Recently Added Within 3 Months ✖Remove constraint Recently Added: Within 3 Months

32. Many Medicaid enrollees with opioid use disorder were treated with medication: however, disparities present concerns

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2023
Subject(s):
Ethnic and Racial Minorities -- statistics & numerical data
Government Regulation
Health Inequities
Healthcare Disparities
Medicaid
Morphinans -- supply & distribution
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
United States

33. Medicare could save millions if it implements an expanded hospital transfer payment policy for early discharges to post acute care

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):
Financial Audit
Government Regulation
Medicare Part A -- economics
Medicare Part A -- organization & administration
Patient Transfer -- economics
Subacute Care -- economics
United States

35. States face ongoing challenges in meeting third-party liability requirements for ensuring that Medicaid functions as the payer of last resort

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, October 2023
Subject(s):
Financial Audit
Government Regulation
Insurance, Health, Reimbursement -- legislation & jurisprudence
Medicaid -- economics
State Health Plans
United States

38. The risk of misuse and diversion of buprenorphine for opioid use disorder in Medicare Part D continues to appear low: 2022

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Buprenorphine
Drug Users -- statistics & numerical data
Government Regulation
Medicare Part D -- economics
Opiate Substitution Treatment
Opioid-Related Disorders -- drug therapy
Prescription Drug Diversion -- statistics & numerical data
United States

39. CMS can do more to leverage Medicare claims data to identify unreported incidents of potential abuse or neglect

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Child Abuse -- legislation & jurisprudence
Elder Abuse -- legislation & jurisprudence
Government Regulation
Medicare -- statistics & numerical data
Vulnerable Populations -- legislation & jurisprudence
United States
Centers for Medicare & Medicaid Services (U.S.)

40. The Food and Drug Administration needs to improve the premarket tobacco application review process for electronic nicotine delivery systems to protect public health

Publication:
[Washington, D.C.] : U.S. Department of Health and Human Services, Office of Inspector General, November 2023
Subject(s):
Electronic Nicotine Delivery Systems -- supply & distribution
Government Regulation
Tobacco Control -- legislation & jurisprudence
United States
United States. Food and Drug Administration